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ARTICLE
Genome-wide screens identify Toxoplasma gondii
determinants of parasite fitness in IFNγ-activated
murine macrophages
Yifan Wang 1,8, Lamba Omar Sangaré1,8, Tatiana C. Paredes-Santos1, Musa A. Hassan 2,3,4,
Shruthi Krishnamurthy1, Anna M. Furuta1, Benedikt M. Markus 5,6, Sebastian Lourido 5,7 &
Jeroen P. J. Saeij 1✉
Macrophages play an essential role in the early immune response against Toxoplasma and are
the cell type preferentially infected by the parasite in vivo. Interferon gamma (IFNγ) elicits a
variety of anti-Toxoplasma activities in macrophages. Using a genome-wide CRISPR screen we
identify 353 Toxoplasma genes that determine parasite fitness in naїve or IFNγ-activated
murine macrophages, seven of which are further confirmed. We show that one of these
genes encodes dense granule protein GRA45, which has a chaperone-like domain, is critical
for correct localization of GRAs into the PVM and secretion of GRA effectors into the host
cytoplasm. Parasites lacking GRA45 are more susceptible to IFNγ-mediated growth inhibition
and have reduced virulence in mice. Together, we identify and characterize an important
chaperone-like GRA in Toxoplasma and provide a resource for the community to further
explore the function of Toxoplasma genes that determine fitness in IFNγ-activated
macrophages.
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T oxoplasma gondii is an obligate intracellular parasite thatcauses disease in immunocompromised individuals, suchas HIV/AIDS patients, and when contracted congenitally1.
It causes lifelong infections by converting from rapidly dividing
tachyzoite stages into encysted slow-growing bradyzoites, which
mainly localize to the brain and muscle tissues. Once established
in the host cell, Toxoplasma resides in a unique replication niche
called the parasitophorous vacuole (PV), which is separated from
the host cytoplasm by the PV membrane (PVM) and does not
fuse with the endolysosomal system2,3.
The cytokine interferon gamma (IFNγ) is essential for the
control of Toxoplasma replication in host cells4. Mice with
macrophages that can no longer respond to IFNγ are extremely
susceptible to Toxoplasma demonstrating their crucial role in
IFNγ-mediated control of Toxoplasma5. IFNγ-induced upregu-
lation of immunity-related GTPases (IRGs) and guanylate bind-
ing proteins (GBPs)6–8 are key mechanisms for controlling
Toxoplasma in mice9–13. IRGs and GBPs can bind and vesiculate
the PVM, eventually leading to the death of the parasite14–17. In
addition, IFNγ induces the production of nitric oxide (NO) and
reactive oxygen species (ROS), which lead to parasite damage and
growth restriction in murine macrophages18. IFNγ stimulation
also changes the metabolism of cells thereby affecting the avail-
ability of nutrients to pathogens19. For example, IFNγ-activated
cells can limit the availability of iron, L-tryptophan, cholesterol,
polyamines, and dNTPs20. The potency of IFNγ-induced anti-
Toxoplasma activities in murine macrophages is parasite-strain-
dependent, with the clonal type II and III strains being more
susceptible to IFNγ-induced growth restriction compared to type
I strains21.
Toxoplasma co-opts host cells by secreting ROP and GRA
effector proteins, from organelles called rhoptries and dense
granules, respectively, into the host cell or onto the PVM
(reviewed in22). ROP18 (encoding a secreted kinase)23,24, and
ROP5 (encoding a member of an expanded family of pseudoki-
nases)25,26 are highly polymorphic and, together with ROP1727
and GRA728,29, account for differences in parasite virulence in
mice by cooperatively blocking IRGs14,30–32 and GBPs6,33 loading
on the PVM. Other parasite-strain-specific effectors include
ROP16 and GRA15, which can affect GBP1 loading on the
PVM34 and macrophage polarization into the classical (M1) or
alternative (M2) activation phenotypes35. GRA15 was recently
shown to recruit IRGB6 and GBP1-5 to the PVM via interacting
with TRAF6, thereby enhancing the susceptibility to IFNγ-
induced parasite elimination36. The pseudokinase ROP54 also
inhibits GBP2 loading on the PVM37. Additional secreted effec-
tors, such as GRA12, affect Toxoplasma survival in murine
macrophages without affecting the loading of IRGB6 to the
PVM38. Besides targeting IFNγ-induced host cell effectors, Tox-
oplasma can directly inhibit IFNγ signaling. For example, through
a GRA (TgIST) secreted beyond the PVM39,40, Toxoplasma can
directly inhibit STAT1 transcriptional activity41–43, an essential
component of the IFNγ signaling pathway44.
The secretion of GRAs beyond the Toxoplasma PVM into the
host cell cytosol is dependent on the MYR complex45–47, which
might form a PVM-localized translocon. A Golgi-resident
aspartyl protease ASP5, which cleaves the Toxoplasma export
element (TEXEL, RRLxx) motif in some GRAs, is required for
exported GRAs to reach the host cytosol and also for the correct
localization of other GRAs confined to the PV48–50. How GRA
effectors that eventually insert into the PVM are kept from
inserting into other membranes during their traffic from the ER
via the Golgi to the dense granules and after their secretion into
the PV lumen is largely unknown. It has been hypothesized that
specific chaperones in the dense granules and in the PV lumen
could bind to these hydrophobic GRA effectors and aid their
traffic to the correct destination51,52. Because PVM-localized
GRAs are at the host-parasite interface they determine the
acquisition of host-derived nutrients, can mediate the evasion of
the host cytosolic immune response, and form the components of
the translocon that secretes other GRAs into the host cytoplasm.
It is therefore likely that these PVM-localized GRAs and the
putative chaperones that mediate the correct trafficking of these
GRAs to the PVM will be important for parasite fitness in IFNγ-
activated cells.
Many Toxoplasma genes determining parasite survival in
IFNγ-activated murine cells were initially identified using genetic
crosses between strains that differ in virulence in mice. However,
this approach fails to identify strain-independent genes. Here we
used a genome-wide loss-of-function screen in the type I (RH)
strain, which is resistant to IRGs/GBPs-mediated killing, to
identify 160 Toxoplasma genes that determine fitness in IFNγ-
activated murine macrophages and 193 genes that determine
fitness in naїve macrophages. Seven of the high-confidence hits
were confirmed by testing single-gene knockouts in functional
parasite growth assays in IFNγ-activated murine macrophages.
We demonstrate that GRA45, one of these hits, has a chaperone-
like function and plays an important role in the trafficking and
localization of GRA effectors to the PVM and the secretion of
GRA effectors beyond the PVM. Δgra45 parasites have enhanced
susceptibility to IFNγ-mediated growth inhibition in murine, rat,
and human macrophages, and significantly reduced virulence in
mice. These results provide functional information to the com-
munity to investigate the mechanism by which other Toxoplasma
genes affect fitness in naїve or IFNγ-activated macrophages.
Results
A loss-of-function screen identifies Toxoplasma genes that
determine fitness in naïve and IFNγ-activated murine macro-
phages. We previously identified Toxoplasma genes that deter-
mine parasite fitness during infection of human foreskin
fibroblasts (HFFs) using a genome-wide loss-of-function
CRISPR/Cas9 screen53. However, it is likely that this set of
fitness-conferring genes varies by host cell type, host species, and
after infection of IFNγ-activated cells. The challenge in Tox-
oplasma genome-wide loss-of-function screens is to maintain the
complexity of the mutant pool during the selection. It was pre-
viously reported that macrophages require stimulation by IFNγ
along with LPS or TNFα to effectively restrict Toxoplasma
growth54. Such stimulated macrophages are extremely effective in
inhibiting Toxoplasma growth—even of virulent strains like the
type I (RH) strain—which would likely create a bottleneck during
the selection of the mutant parasite pool. IFNγ stimulation by
itself was sufficient for a modest but significant inhibition of
Toxoplasma growth in C57BL/6 J murine bone-marrow-derived
macrophages (BMDMs) (Supplementary Fig. 1a). By contrast,
IFNγ+ TNFα stimulation drastically restricted parasite growth
(Supplementary Fig. 1b). Thus, we reasoned that a loss-of-
function screen in macrophages stimulated with IFNγ alone
would reduce the random loss of mutants while, at the same time,
allowing us to identify mutants that are susceptible to IFNγ-
mediated growth restriction. A Toxoplasma mutant pool was
generated by transfecting RH parasites constitutively expressing
Cas9 (RH-Cas9) with a library of sgRNAs containing ten guides
for each of the 8156 Toxoplasma genes53. This mutant pool was
passaged in HFFs to remove mutants with general fitness defects
(e.g., invasion and replication) before growing in naïve and IFNγ-
activated BMDMs for three passages (Fig. 1a, b). Continuous
passages in HFFs served as a control to identify mutants with
fitness defects in naïve BMDMs but not in HFFs. The relative
abundance of sgRNAs was measured using Illumina sequencing
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from the input library and the parasite DNA isolated from the
early passage in HFFs (prior to BMDM infection), three addi-
tional passages on naïve (referred to as Naïve BMDM) or IFNγ-
activated BMDMs (referred to as IFNγ BMDM), and the late
passage in HFFs (referred to as HFF control). We calculated the
average log2 fold change in abundance of sgRNAs targeting a
specific gene in the samples (early passage HFF, Naïve BMDM,
IFNγ BMDM, or HFF control) relative to the input library and
defined it as the “fitness” score for that gene (Supplementary
Data 1). The fitness scores of genes after early passage in HFFs
were highly correlated (r= 0.81 ± 0.03, mean ± SEM, n= 3) with
previously determined HFFs “phenotype” scores53, highlighting
the reproducibility of these screens and demonstrating that up to
the point of infecting the BMDMs, the mutant pool was behaving
as expected.
Because the intracellular environments between murine
BMDMs and HFFs are likely quite different, certain Toxoplasma
genes could be important for fitness in naïve BMDMs but not
HFFs. To identify this set of genes, we determined the probability
of being fitness conferring in naïve BMDMs for each gene by
comparing the fitness (Naïve BMDM vs. HFF control) distribu-
tion to those of 497 control genes from our previous study55.
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Fig. 1 Toxoplasma gondii genome-wide loss-of-function screen in naïve or IFNγ-activated murine bone-marrow-derived macrophages. a Screening
workflow. At least 5 × 108 Cas9-expressing RH parasites were transfected with linearized plasmids containing 10 sgRNAs against every Toxoplasma gene.
Transfected parasites were passaged in HFFs under pyrimethamine selection to remove non-transfected parasites and parasites that integrated plasmids
with sgRNAs targeting parasite genes important for fitness in HFFs. Subsequently, the pool of mutant parasites was either continuously passaged in HFFs
or passaged for three rounds in murine BMDMs that were left unstimulated or prestimulated with IFNγ. The sgRNA abundance at different passages,
determined by illumina sequencing, was used for calculating fitness scores and identifying genes that confer fitness in naïve or IFNγ-activated BMDMs.
b Timeline for the generation of mutant populations and subsequent selection in the presence or absence of murine IFNγ. Times at which parasites were
passaged (P) are indicated. c Correlation between mean parasite gene fitness scores in Naïve BMDMs and HFF control. Orange dots indicate nine high-
confidence candidate genes that confer fitness in naïve BMDMs compared to HFFs (Table 1). d Correlation between mean parasite gene fitness scores in
IFNγ-activated and Naïve BMDMs. Red dots indicate 16 high-confidence IFNγ fitness-conferring candidate genes in murine BMDMs and orange dots the
nine high-confidence genes conferring fitness in naïve BMDMs compared to HFFs (Table 1).
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After removing the genes not expressed in murine macro-
phages56, we identified 193 parasite genes (Supplementary
Fig. 3b), including nine high-confidence hits (Fig. 1c and
Table. 1), with a significant negative enrichment (p < 0.05) and
a large effect size (Cohen’s d ≥ 0.8) compared to control genes
(Supplementary Data 1). To determine if these Toxoplasma genes
shared biological annotation we performed gene set enrichment
analysis (GSEA)57 and Gene Ontology (GO) enrichment analysis
(ToxoDB.org). We found significant enrichment of Toxoplasma
genes involved in folate metabolism, purine metabolism, and
parasite membrane-localized transporters (Supplementary
Data 2), suggesting that nutrient availability to Toxoplasma in
naïve BMDMs and HFFs is variable.
To identify parasite genes that determine fitness in IFNγ-
activated BMDMs, we performed three independent screens with
minor changes to the IFNγ concentration and time of stimula-
tion: 100 ng/mL of IFNγ for 24 h (referred to as screen 1 or S1),
1 ng/mL of IFNγ for 24 h (referred to as screen 2 or S2), and
100 ng/mL of IFNγ for 4 h (referred to as screen 3 or S3; Fig. 1b).
A lower IFNγ concentration (1 ng/mL) induced less parasite
growth inhibition (Supplementary Fig. 1a). In addition, IFNγ
(100 ng/mL) stimulation of murine BMDMs for 4 h induced a
similar but slightly lower expression of gene sets that had ≥2-fold
upregulation in IFNγ stimulation for 24 h (Supplementary Fig. 2a,
b, and Supplementary Data 3). The screens with a lower IFNγ
concentration (S2) or with the high concentration for less time
(S3) indeed reduced the bottleneck and associated stochastic loss
of mutants (Supplementary Fig. 3a). Next, by subtracting the
Naïve BMDM fitness score from the IFNγ BMDM fitness score
we identified 160 parasite genes with expression in murine
macrophages that specifically determine fitness in IFNγ-activated
BMDMs (p < 0.05) with a large effect size (Cohen’s d ≥ 0.8)
(Supplementary Fig. 3c and Supplementary Data 1). GO analysis
showed that genes encoding for proteins with peptidase activity
or DNA-binding/transcription regulator activity were signifi-
cantly enriched (Supplementary Data 2). In astion, we performed
pathway analysis on the RNA-seq data to identify pathways that
are uniquely regulated by IFNγ in the murine macrophages. The
cholesterol biosynthesis pathway (Supplementary Fig. 2c, d) and
many other metabolic pathways were significantly downregulated
in IFNγ-activated BMDMs compared to naïve BMDMs (Supple-
mentary Data 3). Toxoplasma genes involved in lipid biosynth-
esis/transport were enriched in the set of genes that determined
fitness in IFNγ-activated BMDM vs. naïve BMDM (Supplemen-
tary Data 2), suggesting that they are required for responding to
changes in cholesterol levels in IFNγ-activated BMDMs58.
However, ROP18 and GRA12, two Toxoplasma genes determining
RH resistance to IFNγ in murine macrophages30,38, were not
present as candidates likely due to the differences between the
individual screen conditions although they had a 2.2-fold (p=
0.08 and Cohen’s d= 0.65) and 5.2-fold (p= 0.07 and Cohen’s
d= 1.64) lower fitness in IFNγ-activated BMDMs, respectively. It
should be noted that ROP5 was not in our list of hits because the
sgRNA design algorithm excluded ROP5-targeting sgRNAs
because no uniquely targeting sgRNAs could be designed as
ROP5 is a multi-copy gene. Among all the genes conferring
fitness in IFNγ-activated BMDMs, 16 high-confidence candidate
genes (Fig. 1d) are presented in Table 1. ROM1 (TGGT1_200290)
and SUB2 proteases (TGGT1_314500) are important for micro-
neme proteins (MICs) processing and rhoptry protein matura-
tion, respectively59,60, possibly indicating the role of specific
MICs and ROPs in the invasion of and survival in IFNγ-activated
macrophages. Cathepsin CPL (TGGT1_321530) is important for
the digestion of host cytosolic proteins in the parasite lysosomal-
like organelle called the vacuolar compartment61. Four dense
granule proteins GRA22 (TGGT1_215220), GRA45
(TGGT1_315620), GRA46 (TGGT1_208370), and a putative
GRA (TGGT1_263560; Supplementary Fig. 5i) were present as
high-confidence hits. There are three putative DNA repair-like
proteins (TGGT1_269620, TGGT1_209500, and
TGGT1_295340); three proteins involved in intracellular traffick-
ing, putative Cytohesin-3 (TGGT1_232670), putative cytoplasmic
dynein (TGGT1_240980), and putative ribosome associated
membrane protein RAMP4 (TGGT1_276940); one protein
involved in metabolism, putative methylcitrate synthase
(TGGT1_222050); CCDC25 (TGGT1_228300) and putative
IWS1 transcription factor (TGGT1_227560). Taken together,
we identified multiple Toxoplasma candidate genes that confer
fitness specifically in naïve or IFNγ-activated BMDM.
Single parasite gene knockouts from hits identified by CRISPR
screens have fitness defects in IFNγ-activated BMDMs. To
confirm some of the parasite genes that determine fitness in
IFNγ-activated BMDMs, we generated individual knockouts of
four genes (TGGT1_269620, GRA45, TGGT1_232670, and
TGGT1_263560) in luciferase-expressing RH parasites (Supple-
mentary Fig. 4a, d–f). All knockouts had reduced growth com-
pared to wild-type parasites in IFNγ-activated BMDMs as
determined by luciferase assays at 24 h post-infection (p.i.)
(Fig. 2a–d). We previously determined the contribution to the
in vivo fitness of 217 Toxoplasma genes55. Of the 31 genes that
determined in vivo fitness, Δgra22 and ΔTGGT1_269950 parasites
were outcompeted by wild-type in the peritoneum55. GRA22 and
TGGT1_269950 have average fitness scores <−2 in IFNγ-
activated vs. Naïve BMDMs (Table 1) suggesting that the
in vivo fitness of these genes is likely due to their importance in
determining parasite fitness in IFNγ-activated peritoneal macro-
phages. To confirm this, we tested the growth of Δgra22,
ΔTGGT1_269950 and wild-type parasites in IFNγ-activated
BMDMs and found that IFNγ significantly inhibited Δgra22
and ΔTGGT1_269950 parasite growth relative to wild-type
parasites (Fig. 2e, f). Most of the knockouts had no, or a minor,
fitness defect in naïve murine BMDMs (Supplementary Fig. 5a–f)
or mouse embryonic fibroblasts (MEFs) (Supplementary Fig. 5g)
confirming that these genes are specific for conferring fitness in
the presence of IFNγ. ΔTGGT1_263560 and Δgra22 parasites
formed larger plaques compared to wild-type parasites in MEFs,
although this was only significant for ΔTGGT1_263560 (Supple-
mentary Fig. 5g). Although the ΔTGGT1_263560 plaques were
larger, they appeared quite different compared to wild-type pla-
ques; the lysis area contained very few parasites and host cells,
possibly due to an early egress phenotype (Supplementary
Fig. 5h). To test the impact of candidate gene knockouts in a non-
luciferase-expressing type I (RH) strain, we performed a growth
competition assay, in which growth differences between wild-type
and knockouts accumulate over three passages in both naïve and
IFNγ-activated BMDMs. Δgra22 parasites were outcompeted by
wild-type parasites only in the IFNγ-activated BMDMs but not
naïve BMDMs (Fig. 2g). Similar to Δgra22 parasites, parasites
lacking another high-confidence hit, ROM1, (Supplementary
Fig. 4h) were outcompeted by wild-type parasites in IFNγ-
activated BMDMs (Fig. 2h). Thus, the high-confidence parasite
genes identified by our genome-wide loss-of-function screen
indeed determine parasite fitness in IFNγ-activated BMDM.
GRA45 is important for parasite fitness in IFNγ-stimulated
macrophages of other species. Of the seven genes we confirmed
to have a fitness defect in IFNγ-activated BMDM, four genes
(GRA22, GRA45, TGGT1_263560, and TGGT1_269950) encode
known or putative secretory proteins with a predicted signal
peptide (ToxoDB.org). GRA22 was previously characterized and
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shown to contribute to parasite natural egress62, while GRA45
was recently discovered as an ASP5 substrate with unknown
function49. TGGT1_263560 and TGGT1_269950 were annotated
as hypothetical proteins (ToxoDB.org) without previous char-
acterization. We observed that TGGT1_263560 colocalized with
PV-resident GRA2 in intracellular parasites (Supplementary
Fig. 5i) and considered it as a putative GRA. TGGT1_269950 was
predicted as a putative GRA based on published dense granule
proteomic analysis63 and hyperLOPIT spatial proteomic analy-
sis64 (ToxoDB.org). IRG-mediated destruction of the PVM is one
of the main mechanisms by which murine cells inhibit Tox-
oplasma growth. We therefore determined the IRGA6/IRGB6
coating on the vacuole of these knockouts (Fig. 3a, b). We
observed slightly increased loading of IRGA6 (Fig. 3a), and a
significantly larger fraction of ΔTGGT1_263560 and
ΔTGGT1_269950 vacuoles with IRGB6 coating, but no difference
in Δgra45 and Δgra22 parasites (Fig. 3b). This indicates that
GRA45 and GRA22 employ different mechanisms to counter
IFNγ-mediated parasite growth inhibition in murine
macrophages.
Macrophages from different species have different mechanisms
to control Toxoplasma growth8 and therefore knowing if these
genes are important for conferring resistance to IFNγ in other
species could help us narrow down the possible mechanism by
which they do so. To test if these four GRAs are also important
for parasite fitness in IFNγ-activated macrophages of other
species, primary rat BMDMs and human THP-1 macrophages
were stimulated with IFNγ or left unstimulated followed by
infection with wild-type, Δgra45, Δgra22, ΔTGGT1_263560, or
ΔTGGT1_269950 parasites (Fig. 3c–h). Similar to what was
observed in naïve murine BMDMs, these knockouts had no, or a
minor but not significant, fitness defects in naïve rat BMDMs and
human THP-1 macrophages (Supplementary Fig. 6). Although
Δgra22 parasites had significantly higher growth reduction in
primary rat BMDMs activated with IFNγ (5 ng/mL) (Fig. 3c),
Δgra45 parasites were the only knockout that was significantly
more susceptible to IFNγ-mediated growth inhibition compared
to wild-type parasites in both rat and human macrophages
(Fig. 3c–h) indicating GRA45 plays an important function in the
resistance of Toxoplasma to IFNγ in multiple species. We
therefore decided to focus on determining the function of GRA45.
GRA45 has structural homology to protein chaperones and
maintains the correct localization of GRAs to the PVM. GRA45
was recently shown to interact with GRA44 (TGGT1_221870)
and With-No-Gly-loop (WNG)2 kinase (TGGT1_240090), which
also localize to dense granules49. GRA45, GRA44, and WNG2
have orthologues in coccidian species belonging to the Sarco-
cystidae (Neospora caninum, Hammondia hammondi, Cystoisos-
pora suis, Sarcocystis neurona) with >40% amino acid identities
and Eimeriidae (Eimeria spp. and Cyclospora cayetanensis) with
>30% amino acid identities (ToxoDB.org). This is a rather unique
phylogenetic profile as most GRAs are only conserved within the
Toxoplasmatinae suggesting that these GRAs have a conserved
function in these different parasite species. In addition, a GRA45
paralogue (TGGT1_295390) is exclusively expressed in cat
intestinal stages, compared to GRA45, which is highly expressed
in tachyzoite and bradyzoite stages and has moderate expression
levels in sexual stages (ToxoDB.org). Searches for primary
sequence homology or known protein domains failed to provide
any suggestions for putative GRA45 functions. However,
homology searches based on secondary-structure prediction
indicated that the N-terminal region of GRA45 (from amino
acids 72–225) has structural homology to the α-Crystallin domain
(ACD) of small heat shock proteins (sHSPs) (SupplementaryT
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Fig. 7a), which are ATP-independent chaperones that maintain
the native folding status of proteins under stress conditions. The
conserved I/VxI/V motifs present in 90% of sHSPs was conserved
in GRA45 and most of its orthologues (Supplementary Fig. 7a).
The most significant structural homology was to Aggregation
Suppressing Protein A (AgsA) from Salmonella typhimurium65
and HSP20 from Xylella fastidiosa66 (Supplementary Fig. 7a). The
GRA45 C-terminal region (amino acids 260–335) had structural
slogy to DUF1812 domains67 and Mfa268, which share a
transthyretin-like fold (Supplementary Fig. 7a). Transthyretin
family members are known to bind and transport lipids such as
retinol and thyroxine69. In addition, the top 10 models (TM-score
0.9–0.69) with GRA45 structural homology, as predicted by I-
TASSER70, are predicted to bind hydrophobic substrates as they
have acyltransferase domains. Overall these data indicate GRA45
harbors a potential chaperone-like function with preference for
hydrophobic substrates. Consistent with published results that
GRA45 remains in the PV lumen after secretion49, we observed
that almost all GRA45 colocalized with PV-resident GRA1 and
GRA2 in the PV lumen but only partially with PVM-associated
GRA5 and GRA7, even though GRA45 colocalized with all these
GRAs to dense granules in extracellular parasites (Supplementary
Fig. 7b). Thus, GRA45 is unlikely to be a Toxoplasma effector that
directly interacts with host proteins to modulate or inhibit IFNγ-
induced anti-Toxoplasma activities.
Based on its structural homology to sHSPs, we hypothesized
that instead of directly neutralizing IFNγ-mediated inhibition,
GRA45 might perform a chaperone-like function for other GRA
effectors, of which some are known to counteract the murine
IFNγ response28,29,38. GRAs with a hydrophobic domain (such as
a transmembrane domain or amphipathic α-helices) have
peculiar trafficking and do not traffic to the parasite plasma
membrane but instead traffic to the dense granules where they
exist in partially soluble and aggregated states51. What prevents
the aggregation of these hydrophobic domain-containing proteins
in dense granules or insertion of their transmembrane domain
a
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Fig. 2 Validation of candidate genes that determine parasite fitness in IFNγ-stimulated murine BMDMs. a–f Murine BMDMs prestimulated with IFNγ
(1 or 5 ng/mL) or left unstimulated for 24 h were infected with luciferase-expressing wild-type (WT) parasites or with parasites in which TGGT1_269620
(a, n= 6), GRA45 (b, n= 5), TGGT1_232670 (c, n= 5), TGGT1_263560 (d, n= 5), GRA22 (e, n= 4), or TGGT1_269950 (f, n= 5) was knocked out (MOI of
0.25). Parasite growth for each strain was measured by luciferase assay at 24 h p.i. Parasite growth in IFNγ-activated BMDMs is expressed relative to
growth in naïve BMDMs. Data are displayed as mean ± SEM with independent experiments indicated by the same color dots. The significant difference
between WT and knockout was analyzed with two-tailed paired t-test. g, h Growth competition assay between GFP-positive WT parasites and GFP-
negative g Δgra22 or h Δrom1 parasites was performed in murine BMDMs prestimulated with 1 ng/mL IFNγ or left unstimulated for three passages. The
percentage of Δgra22 or Δrom1 was determined at the start of the competition and after three passages by plaque assay measuring the GFP-negative
plaques vs. total plaques. Data are displayed as mean ± SEM with independent experiments (n= 3) indicated by the same color dots. The significant
difference between the ratio of WT vs. knockout before and after competition was analyzed with two-tailed paired t-test.
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into the ER membrane or the dense granule membrane is
unknown but has been hypothesized to be mediated by dense
granule protein chaperone(s)51,52. To test the hypothesis that
GRA45 is a dense granule protein chaperone, we first examined
the solubility of hydrophobic GRA2, which has two amphipathic
helices that mediate its membrane association post secretion71. In
parasite lysates generated by freeze/thawing, GRA2 was in both
pellet and supernatant fractions in wild-type, Δgra45, and Δgra45
parasites complemented with a C-terminal HA-tagged version of
GRA45 (Δgra45+GRA45HA, Supplementary Fig. 4b, d) and ran
according to its corresponding molecular weight (MW) (Fig. 4a).
In addition to its predicted size, GRA2 appeared at a much higher
MW in the pellet fraction from all strains suggesting insoluble
protein aggregates as the bands were not completely separated
a b
IRGB6IRGA6
ToxoToxo
DAPIDAPI
d
Merge Merge
ec
g hf
W
T
15
100
80
60
40
20
0
100
80
60
40
20
0
100
120
140
80
60
40
20
0
n.s. n.s. n.s.
n.s.
p = 0.006
p = 0.0002p = 0.03
p = 0.0002
p = 0.04
p = 0.001
p = 0.02
n.s.
n.s.
n.s.
n.s. n.s. n.s. n.s. n.s.n.s.
n.s.
n.s. n.s.
n.s.
10
lR
G
A
6 
va
cu
ol
es
 (
%
)
R
el
at
iv
e 
pa
ra
si
te
 g
ro
w
th
vs
. n
aï
ve
 B
M
D
M
s 
(%
)
R
el
at
iv
e 
pa
ra
si
te
 g
ro
w
th
vs
. n
aï
ve
 m
ac
ro
ph
ag
es
 (
%
)
100
80
60
40
20
0
R
el
at
iv
e 
pa
ra
si
te
 g
ro
w
th
vs
. n
aï
ve
 m
ac
ro
ph
ag
es
 (
%
)
100
80
60
40
20
0
R
el
at
iv
e 
pa
ra
si
te
 g
ro
w
th
vs
. n
aï
ve
 m
ac
ro
ph
ag
es
 (
%
)
100
80
60
40
20
0
R
el
at
iv
e 
pa
ra
si
te
 g
ro
w
th
vs
. n
aï
ve
 m
ac
ro
ph
ag
es
 (
%
)
R
el
at
iv
e 
pa
ra
si
te
 g
ro
w
th
vs
. n
aï
ve
 B
M
D
M
s 
(%
)
5
0
Rat BMDMs
1 ng/mL 5 ng/mL 1 ng/mL 5 ng/mL 2.5 ng/mL 5 ng/mL
2.5 ng/mL 5 ng/mL 2.5 ng/mL 5 ng/mL 2.5 ng/mL 5 ng/mL
lFNγ concentration
Rat BMDMs THP-1 macrophages
lFNγ concentration lFNγ concentration
THP-1 macrophages THP-1 macrophages THP-1 macrophages
lFNγ concentration lFNγ concentration lFNγ concentration
15
10
lR
G
B
6 
va
cu
ol
es
 (
%
)
5
0
W
T
W
T
W
T
W
T
W
T
Δg
ra
22
W
T
W
T
W
T
W
T
Δg
ra
45
Δg
ra
22
W
T
Δg
ra
45
Δg
ra
22 W
T
Δg
ra
45
Δg
ra
22
ΔT
GG
T1
_2
69
95
0
ΔT
GG
T1
_2
69
95
0
ΔT
GG
T1
_2
69
95
0
ΔT
GG
T1
_2
63
56
0
ΔT
GG
T1
_2
63
56
0
ΔT
GG
T1
_2
63
56
0
W
T
W
T
Δg
ra
45
Δg
ra
22
ΔT
GG
T1
_2
69
95
0
ΔT
GG
T1
_2
63
56
0
Δg
ra
22
W
T
W
T
Δg
ra
45
Δg
ra
45
ΔT
GG
T1
_2
63
56
0
ΔT
GG
T1
_2
69
95
0
ΔT
GG
T1
_2
69
95
0
ΔT
GG
T1
_2
63
56
0
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-18991-8
8 NATURE COMMUNICATIONS |         (2020) 11:5258 | https://doi.org/10.1038/s41467-020-18991-8 | www.nature.com/naturecommunications
during the gel migration. As a control, we used the parasite
plasma membrane protein SAG1, which traffics to the parasite
surface independent of the dense granules trafficking pathway.
No high MW bands of SAG1 were observed in any of the parasite
strains (Supplementary Fig. 10) indicating that the high MW
bands of GRA2 were specific to dense granule proteins. After
treatment with non-ionic detergents (NP-40), which solubilize
membrane proteins by associating with their hydrophobic
surface51, monomeric GRA2 was completely solubilized and
released into the supernatant fraction in all the strains (Fig. 4a).
Although the high MW bands were also solubilized after NP-40
treatment, consistently less solubilization of GRA2 high MW
bands was observed in Δgra45 parasites compared to wild-type
and Δgra45+GRA45HA parasites (Fig. 4a and Supplementary
Fig. 8a). We then observed the solubility of GRA7, which contains
a transmembrane domain but localizes to the dense granule core
and does not integrate into the dense granule membrane72,73. In
all strains, GRA7 mainly presented in the pellet fraction with both
monomeric bands and high MW bands (Fig. 4b). Similar to
GRA2, high MW GRA7 in Δgra45 parasites was more resistant to
NP-40-induced solubilization (Fig. 4b); however, because of
variability between experiments there was no significant differ-
ence between wild-type and Δgra45 parasites (Supplementary
Fig. 8b). No high MW bands or monomeric GRA7 were observed
in Δgra7 parasites (Supplementary Fig. 4i) indicating that the
high MW bands were not a specific detection of other
Toxoplasma proteins (Supplementary Fig. 8c).
To confirm that transmembrane domain-containing GRAs
were affected in Δgra45 parasites, we examined the localization of
several GRAs after exocytosis of the dense granules based on their
membrane association properties: GRA5, is a PVM-integrated
protein with its N-terminus faces to the host cytosol;74,75 and
GRA7, associates with IVN and PVM72,73, and strands extending
from PVM into the host cytosol;76 MAF1, integrates into the
PVM with its C-terminus exposed to host mitochondria77. We
observed that a significantly larger fraction of GRA5 and GRA7
was retained in the PV lumen in Δgra45 parasites compared to
wild-type and Δgra45+GRA45HA parasites (Fig. 4c, d). In
Δgra45 parasites, PVM localization of MAF1 was completely
abolished at the early infection stage (4 h p.i.) (Fig. 4e) and
significantly reduced at 24 h p.i. (Fig. 4f). In addition to
transmembrane GRAs, we observed that GRA23, which is an α-
helical enriched GRA that is almost exclusively localized to the
PVM78,79, was mislocalized to the PV lumen in Δgra45 parasites
(Fig. 4g). GRA23 localization remained normal in Δmyr1
parasites (Supplementary Fig. 4f), which served as a control as
it was shown that parasites lacking MYR1 have normal function
of PVM-localized GRAs45. These results demonstrate that GRA45
plays a critical role in the correct trafficking of PVM-integrated or
-associated GRAs after exocytosis of dense granules. GRA44, as
the known GRA45 interaction partner, has no predicted
hydrophobic domain but localizes to the PV49,80. In contrast to
the localization changing from PVM to the PV lumen for above
GRAs, GRA44 resided inside the cytosol of Δgra45 parasites
instead of being secreted into the PV (Fig. 4h) suggesting that the
trafficking of GRA44 through the secretory pathway depends on
GRA45, probably via directly interacting with GRA45.
Given that several PVM-localized GRAs and GRA44 appeared
to be mislocalized in Δgra45 parasites, we hypothesized that
components of the translocon involved in GRA translocation
across the PVM could also be mislocalized. To test this
hypothesis, we generated Δgra45 parasites in a strain where
MYR1 was endogenously tagged with 3xHA epitopes (Supple-
mentary Fig. 4c, j) and determined the solubility of MYR1 in
Δgra45 parasites (Supplementary Fig. 8d). Although we did not
observe any high MW bands corresponding to MYR1 in Δgra45
parasites, MYR1 was more resistant to detergent extraction and
less abundant in the soluble fraction of Δgra45 parasites
compared to wild-type parasites (Supplementary Fig. 8e) indicat-
ing GRA45 is partially required for the solubility of MYR1.
However, it is unclear what happens to the N-terminus of MYR1
in Δgra45 parasites, as MYR1 is cleaved by ASP5 into an N-
terminal and C-terminal polypeptide45,81 and only the C-terminal
MYR1 polypeptide was observed for this experiment. Further-
more, MYR2, MYR3, and MYR4 are also involved in GRA
effector translocation into the host cell46,47. We therefore
indirectly assessed if a translocon-mediated phenotype was
affected in Δgra45 parasites by determining GRA16 and GRA24
export beyond the PVM. Indeed, GRA16 and GRA24 were no
longer exported beyond the PVM in Δgra45 parasites, as observed
by their absence from host nuclei, which was similar to what we
observed in Δmyr1 parasites (Fig. 4i, j). Overall, these data
indicate that GRA45 functions as a potential chaperone protein
important for the correct localization of several GRAs to the PVM
and the correct trafficking of GRA effectors to the host cell.
The conserved sHSP signatures are critical for the chaperone-
like function of GRA45. To confirm the chaperone-like function
of GRA45, we generated parasites expressing C-terminal HA-
tagged GRA45 without its ACD (ΔACD, Fig. 5a and Supple-
mentary Fig. 4k), which is the central structure of sHSPs and the
key element for homodimer formation and substrate binding82.
The parasite strain expressing GRA45 with C-terminal trans-
thyretin-like fold deletion (ΔTL) was generated at the same time
(Fig. 5a and Supplementary Fig. 4k). To avoid a massive con-
formational change caused by deletion of a large portion of the
protein, we also generated parasites harboring GRA45 with var-
ious point mutations including VKV139–141/AAA together with
Fig. 3 Δgra45 parasites have enhanced susceptibility to IFNγ-mediated growth inhibition in rat BMDMs and human THP-1 macrophages. a, b Murine
BMDMs prestimulated with 5 ng/mL of IFNγ for 24 h were infected with luciferase-expressing WT, Δgra45, Δgra22, ΔTGGT1_263560, or ΔTGGT1_269950
parasites (MOI of 0.5) for 1 h and subsequently fixed, permeabilized, and stained for IRGA6 (a) or IRGB6 (b). A representative image from three
independent experiments is shown on the left (Scale bar= 5 μm). Quantification of IRGA6/IRGB6 loading on at least 200 vacuoles is presented on the
right panel. Data are displayed as mean ± SEM with independent experiments indicated by the same color dots. The significant difference between WT and
knockout was analyzed with two-tailed paired t-test. c, d Brown Norway rat BMDMs prestimulated with or without IFNγ (1 ng/mL or 5 ng/mL) were
infected with luciferase-expressing WT, Δgra45 (c), Δgra22 (c), ΔTGGT1_263560 (d), or ΔTGGT1_269950 (d) parasites (MOI of 0.25) for 24 h. Parasite
growth for each strain was measured by luciferase assay and the growth in IFNγ-activated BMDMs is expressed relative to growth in naïve BMDMs. Data
are displayed as mean ± SEM with independent experiments (n= 3) indicated by the same color dots. The significant difference between WT and knockout
was analyzed with two-tailed paired t-test. e–h PMA-differentiated THP-1 macrophages prestimulated with or without IFNγ (2.5 or 5 ng/mL) were infected
with luciferase-expressing WT, Δgra45 (e, n= 4), Δgra22 (f, n= 3), ΔTGGT1_263560 (g, n= 3), or ΔTGGT1_269950 (h, n= 3) parasites (MOI of 0.25) for
24 h. Parasite growth for each strain was measured by luciferase assay and the growth in IFNγ-activated THP-1 macrophages is expressed relative to
growth in naïve THP-1 macrophages. Data are displayed as mean ± SEM with independent experiments indicated by the same color dots. The significant
difference between WT and knockout analyzed with two-tailed paired t-test.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-18991-8 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:5258 | https://doi.org/10.1038/s41467-020-18991-8 |www.nature.com/naturecommunications 9
VEV162–164/AAA (referred to as VxV/AAA), IDV205–207/AAA
(referred to as 1st IxV/AAA), IDV291–293/AAA (referred to as
2nd IxV/AAA), and IDV205–207/AAA together with IDV291–293/
AAA (referred to as IxV/AAA) (Fig. 5a and Supplementary
Fig. 4k). These mutant sites are the conserved I/VxI/V motifs of
sHSPs, which direct the formation of sHSP oligomers via binding
to hydrophobic pockets of the homodimer82,83. We found that in
addition to presenting in dense granules of the extracellular
parasites all the GRA45 mutants also localized to compartments
peripheral to the parasite nucleus (Fig. 5b), which is reminiscent
of the organelles in the early secretory pathway, such as endo-
plasmic reticulum (ER), Golgi and endosome-like compartment.
This change of GRA45 localization in the mutant strains was also
observed in the intracellular parasites residing in the vacuole
(Fig. 5c), suggesting that a higher level of architecture (e.g., oli-
gomer) is needed for its trafficking to dense granules and secre-
tion. Surprisingly, in these GRA45 mutant parasite strains GRA7
completely colocalized with GRA45 in extracellular parasites
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including dense granules as well as the perinuclear compartments
(Fig. 5b), suggesting that GRA45 has a chaperone-like function
important for the trafficking of GRAs from early secretory
organelles to the dense granules. In addition, we noticed that the
total amount of GRA7 in Δgra45 parasites detected by immu-
nofluorescence assay was significantly less compared to Δgra45+
GRA45HA parasites (Fig. 5b and Supplementary Fig. 8a) although
it still localized to dense granules (long exposure in Supplemen-
tary Fig. 8a). This could be due to a large portion of GRA7
remaining insoluble (Fig. 4b) and inaccessible to antibodies in
Δgra45 parasites. To determine if the localization of GRAs on the
PVM was affected in these GRA45 mutant strains, we observed
the localization of MAF1 at 4 h (Fig. 5d) and 24 h p.i. (Supple-
mentary Fig. 9b). Like in Δgra45 parasites, MAF1 was almost
completely retained in the PV lumen of all the mutant strains
except for Δgra45+GRA452nd IxV/AAAHA parasites which had
~15% of PVM-localized MAF1 (Supplementary Fig. 9c). These
mutations in GRA45 also resulted in the absence of translocation
of GRA16 and GRA24 to the host nucleus (Fig. 5e, Supplemen-
tary Fig. 9d, e). Since these GRA45 mutant strains have a similar
phenotype as Δgra45 parasites, we determined the susceptibility
of these parasites to IFNγ-induced parasite growth inhibition in
murine BMDMs (Fig. 5f). Except for Δgra45+GRA45VxV/AAAHA
and Δgra45+GRA452nd IxV/AAAHA parasites, all the GRA45
mutant parasites had significantly reduced growth in IFNγ-
activated murine BMDMs. Among the mutants, Δgra45+
GRA45ΔACDHA, Δgra45+GRA45ΔTLHA, and Δgra45+
GRA45IxV/AAAHA parasites had similar level of growth as Δgra45
parasites suggesting both the ACD and TL domains as well as
both IxV motifs are important for correct trafficking of GRA
effector(s) neutralizing the IFNγ responses in murine macro-
phages. Similar to Δgra45 parasites, none of the mutants had a
growth defect in naïve murine BMDMs (Supplementary Fig. 5f).
Taken together, GRA45 has conserved sHSP functional sig-
natures, which are critical for the trafficking of GRAs (including
GRA45 itself) to dense granules and their final destinations.
GRA45 is important for parasite virulence. Since the data
suggest that GRA45 affects both the correct localization of GRAs
to the PVM and the export of GRAs beyond the PVM, it is
unclear if the fitness defect of Δgra45 parasites in IFNγ-activated
BMDMs was due to the defect of PVM-localized GRAs or
exported GRAs. However, the translocon components MYR1/2/
3/4 did not emerge as hits in our loss-of-function screen in IFNγ-
activated BMDMs (Fig. 6a). GRA45 has a significantly lower IFNγ
BMDM vs. Naïve BMDM fitness compared to MYR1, MYR2, and
MYR3 across the three screens (Fig. 6b). Together with the data
that Δgra45+GRA45VxV/AAAHA and Δgra45+GRA452nd IxV/AAA
HA parasites did not export GRA16 and GRA24 beyond the
PVM (Fig. 5e) but only had minor growth reduction in IFNγ-
activated murine BMDMs (Fig. 5f) suggests that GRA export is
not involved in resistance to IFNγ-induced parasite growth
inhibition. To confirm this, we compared side-by-side the sus-
ceptibility of Δgra45 and Δmyr1 parasites to IFNγ-mediated
growth inhibition. In murine BMDMs prestimulated with
increasing concentrations of IFNγ, we observed that Δgra45, but
not Δmyr1, parasites were more susceptible than either wild-type
or Δgra45+GRA45HA parasites to IFNγ-mediated growth
inhibition (Fig. 6c). To determine if these in vitro differences also
translated to differences in virulence in mice, we intraperitoneally
(i.p.) infected mice with 100 tachyzoites of wild-type, Δgra45,
Δmyr1, Δgra45+GRA45HA parasites and monitored parasite
virulence. Consistent with the in vitro data, Δgra45, but not
Δmyr1, parasites were significantly less virulent compared to
wild-type or GRA45 complemented parasites (Fig. 6d). These
data indicate that MYR-component trafficking and function only
partially explain the effects of GRA45 on IFNγ resistance and
parasite virulence.
Discussion
In this study, we performed a genome-wide loss-of-function
screen and identified the Toxoplasma genes that determine fitness
in naïve or IFNγ-activated murine BMDMs. Evading the host
immune response at the site of infection and reaching immune-
privileged organs is essential for Toxoplasma to establish a life-
long chronic infection. It is likely that some of the Toxoplasma
genes that determined fitness at the site of infection were
important for resisting the anti-Toxoplasma activities in IFNγ-
activated cells or determined parasite growth and survival inside
macrophages, the cell type preferentially infected by Toxoplasma
in vivo. We and another group recently determined the in vivo
fitness contribution of a subset of Toxoplasma genes encoding
secretory proteins, mainly including ROPs and GRAs, in the
mouse peritoneum and in distant organs55,84. Five genes (GRA22,
TGGT1_269950, GRA38, TGGT1_205350, and TGGT1_269950)
conferring in vivo fitness were also fitness-conferring genes in
IFNγ-activated murine macrophages revealing the in vivo
phenotype of these genes is likely due to their importance in
maintaining parasite growth in IFNγ-activated peritoneal
macrophages.
One of the most significant parasite genes conferring fitness in
IFNγ-activated BMDMs was GRA45. Unlike previously described
GRAs that are involved in parasite virulence, GRA45 is not a
parasite effector that directly modulates host cell signaling path-
ways or inhibits host immunity. Our data indicate that GRA45 is
an important chaperone-like protein that determines the correct
trafficking of PVM-localized GRA effectors to their final desti-
nation, likely via maintaining their native folding status in the
Fig. 4 In Δgra45 parasites other GRAs mislocalized after secretion into the vacuole. a, b PBS or NP-40-treated pellet (P) and supernatant (S) fraction of
extracellular parasite were detected with antibodies against GRA2 (a) or GRA7 (b). SAG1 was used as the parasite loading control. The image is
representative of 4 independent experiments. c–f HFFs infected with indicated parasites for 4 h (e) or 24 h (c, d, f) were stained with antibodies against
GRA5 (c), GRA7 (d), or MAF1 (e, f). The images are representative of results from three independent experiments (scale bar= 5 μm). The percentage of
vacuoles with only PV-lumen staining was quantified as shown on the right. g HFFs infected with indicated parasites transiently expressing GRA23-HA
were stained with antibodies against SAG1 (green) and the HA epitope (red). The images are representative of results from three independent experiments
for WT and Δgra45 parasites with two experiments for Δmyr1 parasites (scale bar= 5 μm). The percentage of vacuoles with only PV-lumen
GRA23 staining was quantified as shown on the right. h HFFs infected with indicated parasites transiently expressing GRA44-Myc were stained with
antibodies against the Myc epitope. The images are representative of results from three independent experiments (scale bar= 2 μm). The percentage of
vacuoles with only cytosolic GRA44 staining was quantified as shown on the right. i, j HFFs infected with indicated parasites transiently expressing GRA16-
HA-FLAG (i) or GRA24-HA-FLAG (j) were subjected to the immunofluorescent assay. The images are representative of results from three independent
experiments (scale bar= 10 μm). The nuclear intensity of GRA16 (i) or GRA24 (j) was quantified as shown on the right. Data are displayed as mean ± SEM
with independent experiments indicated by the same color dots. Statistical analysis was done by one-way ANOVA with Tukey’s multiple comparisons test
(c–f, h–j) and two-tailed paired t-test (g) due to different n between Δmyr1 and Δgra45.
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secretory pathway. Among all the characterized ASP5 substrates,
GRA45 best phenocopies the mislocalization of GRAs to PVM
caused by the deletion of ASP548,81. Due to the absence of a
TEXEL motif in some of the PVM-localized GRAs, for example
GRA7 and MAF1, it is reasonable to believe that the
mislocalization of GRA7 and MAF1 in Δasp5 parasites is due to
failed GRA45 processing. Many PVM-integrated or -associated
GRAs possess a hydrophobic domain and form high MW com-
plexes while trafficking through the secretory pathway and exist
as a mix of soluble and aggregated states before dense granule
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exocytosis51,85,86. In bacteria and plants, the sHSPs form dynamic
assemblies with the early-unfolding intermediates of their sub-
strates to prevent tight protein aggregate formation upon
unfolding stress conditions82. The ACD homodimer subunits of
sHSP sequester the substrates and preserve them in a complex
core structure with a dynamic shell composed of a multitude of
diverse oligomerization states driven by the docking of the I/VxI/
V motifs to a hydrophobic groove presented in the subunits82.
Mutations in the I/VxI/V motifs causes dissociation of oligo-
merized ACD homodimer subunits resulting in loss of the
chaperone-like activity83,87. Since GRA45 deficient in its con-
served sHSP domain/motifs caused transmembrane domain-
containing GRAs to partially remain in the early secretory com-
partments and to mislocalize after secretion, it is likely that
GRA45 shields the hydrophobic domain of these GRAs to protect
them from uncontrolled aggregation during their trafficking in
the secretory pathway. The data also suggest the dimerization/
oligomerization of GRA45 is required for its own trafficking to
dense granules possibly via an ER/Golgi-resident sorting receptor,
which only recognizes GRA45/substrate complexes. Thus, dele-
tion of GRA45 had pleiotropic effects, which is the most likely
explanation for its importance in conferring fitness in IFNγ-
activated macrophages of multiple species. In addition to PVM-
localized GRAs, GRA16, and GRA24, which are normally secre-
ted beyond the PVM, are no longer secreted in Δgra45 parasites.
However, it is unlikely that the fitness defect of Δgra45 parasites
was due to the defect in GRA effector export beyond the PVM as
Δmyr1 parasites were not significantly more susceptible to IFNγ
than wild-type parasites. The in vivo fitness of Δgra45 parasites
also differed from Δmyr1 parasites, which is consistent with our
previous in vivo screen in whichMYR1 had no peritoneum fitness
defect55. However, studies in the less virulent type II strain
showed that individual MYR1 knockout parasites, but not MYR1
knockout parasites in a pool of other mutants, lose their virulence
in vivo45,84. This is most likely due to abolished translocation of
the GRA effector TgIST in Δmyr1 parasites as deletion of TgIST
in type II parasites resulted in attenuated virulence in mice39,40.
However, deletion of TgIST had no effect on parasite suscept-
ibility in IFNγ-prestimulated cells39,40. It is therefore likely that
the susceptibility of Δgra45 parasites is due to the combined effect
of mislocalized-PVM proteins. For example, the PVM-localized
GRA23 and GRA17 form the nutrient pore in the PVM and
GRA23 was mislocalized in Δgra45 parasites. GRA23 also had a
~2-fold stronger fitness defect in Naïve BMDMs vs. HFF con-
trol suggesting that Toxoplasma might be more reliant on
nutrient acquisition via PVM nutrient pores in BMDMs. We
cannot exclude the possibility that the majority of IFNγ resistance
is dependent on an unknown PVM-localized GRA, of which the
localization to the PVM is mediated by GRA45. Further experi-
ments will be needed to identify such PVM-localized GRA
effector(s).
In addition to GRA45, there are other GRAs involved in
protein trafficking from parasite plasma membrane to PVM. It
was recently shown that phosphorylation of GRAs by WNG1, a
closely related family member of WNG2, after exocytosis from
the dense granules is important for the correct localization of
transmembrane domain-containing GRAs52. We have shown
that GRA42 and GRA43 also play a role in the correct traf-
ficking of PVM-localized GRAs and that in Δgra42 or Δgra43
parasites GRA23 and GRA35 are mislocalized79. Exactly how
WNG1, GRA42, GRA43, and GRA45 function in the GRA
trafficking pathway is currently unknown. It is likely that
Toxoplasma has different PV-lumen-localized chaperones and
different transport systems to mediate the trafficking of dif-
ferent classes of membrane proteins (e.g., integral vs. peripheral
vs. α-helical). Possibly genes encoding for some of these were
hits in our screen. Future more focussed screens and testing
additional knockouts of hits from our screen will allow the
identification of other Toxoplasma genes that mediate the
correct trafficking of GRAs to their final destination and
understand the precise mechanism by which they influence the
localization of GRAs.
In murine cells activated with IFNγ, recruitment of IRGs and
GBPs onto the PVM leading to the subsequent vacuole disruption
are the predominant mechanisms for controlling Toxoplasma6,9–17.
We found two putative GRAs (TGGT1_263560 and
TGGT1_269950) inhibited accumulation of IRGB6 on the PVM,
which likely explains their role in parasite fitness in IFNγ-activated
murine macrophages. Because the two GRAs were not identified as
components of the ROP5/18 complex from previous proteomic
studies27,28, it is unlikely they directly bind to the IRGB6 on the
PVM and inhibit its polymerization. A recent study suggested that
IRGB6 recruitment is dependent on the recognition of specific
phospholipids present on the PVM88. It is therefore also possible
that the increased IRGB6 loading on the vacuole of
ΔTGGT1_263560 or ΔTGGT1_269950 parasites is due to a change
of PVM lipid composition.
Our RNA-seq data showed that IFNγ modulates cholesterol
biosynthesis and many other nutrient pathways in murine
macrophages. IFNγ stimulation significantly downregulated the
cholesterol biosynthesis pathway in BMDMs as has been shown
by others58. Thus, it is not surprising that many genes involved
in lipid biosynthesis or transport were enriched in IFNγ-
activated BMDMs. For example, TGGT1_205350 and
TGGT1_242380, members of GNS1/SUR4 family involved in
long-chain fatty acid elongation and sphingolipid/ceramide
Fig. 5 The α-Crystallin domain (ACD) and I/VxI/V motifs are critical for the chaperone-like function of GRA45. a Schematic illustration of the
constructs used for generation of the parasite expressing full-length GRA45 or GRA45 with indicated mutations. ACD and TL indicate predicted α-
Crystallin domain and transthyretin-like fold, respectively. The conserved VxV or IxV motifs are indicated accordingly. b Extracellular Δgra45 parasites or
Δgra45 parasites complemented with C-terminal HA-tagged wild-type or indicated mutant version of GRA45 were fixed with methanol and staining with
indicated antibodies. The images are representative of results from two independent experiments (scale bar= 2 μm). c HFFs infected with indicated
parasite strains for 24 h were fixed and stained with antibodies against HA epitope. The images are representative of results from two independent
experiments (scale bar= 5 μm). d HFFs infected indicated parasite strains for 4 h were stained with antibodies against MAF1. The images are
representative of results from two independent experiments (scale bar= 2 μm). e Δgra45 or Δgra45 complemented with wild-type or indicated mutant
version of GRA45 were transiently transfected with GRA16-Ty (upper) or GRA24-Ty (lower) expressing plasmids and immediately used to infect HFFs and
fixed at 24 h p.i. and subjected to the immunofluorescent assay with antibodies against Ty epitope. The images are representative of at least 40 host cells
containing a single parasitophorous vacuole with four or more parasites (scale bar= 10 μm). f Murine BMDMs prestimulated with 5 ng/mL of IFNγ or left
unstimulated for 24 h were infected with indicated parasite strains. Twenty-four hours p.i. parasite growth for each strain was measured by luciferase
assay. Parasite growth in IFNγ-activated BMDMs is expressed relative to growth in naïve BMDMs. Data are displayed as mean ± SEM with independent
experiments (n= 3) indicated by the same color dots. The significant difference between WT and knockout (or mutant strains) was analyzed with one-way
ANOVA with Tukey’s multiple comparisons test and the p values are indicated above the columns.
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biosynthesis; TGGT1_266640 (Acetyl-coenzyme A synthetase),
enzymes involved in fatty acid production and metabolism;
GRA38, an orthologue of GRA39 of which the knockout has
been shown to accumulate lipid;63 and ATP-binding cassette
transporters ABCG96, which have been shown to mediate cho-
lesterol transport89. However, it is well known that Toxoplasma
is a glutton for host-derived lipids and takes up more than it can
safely store in lipid droplets. Because excess lipids, especially free
cholesterol, can be toxic, Toxoplasma might import more cho-
lesterol and the inability to export excess cholesterol in these cells
is likely toxic to the parasite90. It is, therefore, possible that
Toxoplasma needs to modify its acquisition/export or own pro-
duction of lipids in IFNγ-stimulated BMDMs.
It is worth noticing that there was variation in IFNγ BMDM
fitness scores likely resulting in a substantial number of false
negatives due to differences in IFNγ concentration and incuba-
tion time between the individual screens. For example, deletion of
ROP18 resulted in a fitness defect in IFNγ-activated BMDMs in
two out of three screens (IFNγ vs. Naïve BMDM fitness scores of
S1, S2, and S3 are −2.03, −0.13, and −1.35, respectively). Given
that S1 and S3 were performed in macrophages activated with
100 ng/mL of IFNγ, parasites deficient in ROP18 might only be
susceptible to growth inhibition induced with a higher amount of
IFNγ. GRA12 had remarkably lower fitness in BMDMs with
longer (24 h) IFNγ stimulation (S1=−3.19 and S2=−4.15)
compared to 4 h of IFNγ incubation (S3= 0.21) suggesting that
the length of IFNγ stimulation probably determined the efficiency
of parasite restriction. In addition, our screen likely missed
parasite genes that determine fitness in HFFs but that might have
an even larger effect on fitness in naïve or IFNγ-activated
BMDMs (for example ASP548) because we started our screen
after three to four passages in HFFs. At that point, mutants with a
fitness defect in HFFs would have already been depleted and
therefore, might not have met the threshold to be included in our
analysis. The large number of host cells needed to maintain the
complexity of the genome-wide library of parasite mutants made
it impractical to directly perform the screen in BMDMs. Future
focused screens could use the data from our screens as a starting
point to identify additional parasite genes that mediate fitness in
naïve or IFNγ-activated BMDMs.
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Fig. 6 Compared to Δmyr1 parasites, Δgra45 parasites are more susceptible to IFNγ and less virulent in mice. a Toxoplasma genes that have at least four
sgRNAs present after the 3rd passage in naïve BMDM in the three independent screens are rank-ordered according to their IFNγ vs. Naïve BMDM fitness
scores. Data are displayed as average fitness scores (black plots) ± SEM (gray lines). b Mean IFNγ vs. Naïve BMDM fitness of GRA45, MYR1, MYR2, MYR3,
and MYR4. Data are displayed as mean ± SEM with independent screens (n= 3) indicated by the same color dots (S1: white; S2: blue; S3: red). The
significant difference was analyzed with one-way ANOVA with Tukey’s multiple comparisons test. cMurine BMDMs prestimulated with or without IFNγ (1,
5, 10, or 50 ng/mL) were infected with luciferase-expressing WT, Δmyr1, Δgra45, or Δgra45+ GRA45HA parasites (MOI of 0.25) for 24 h. Parasite growth
for each strain was measured by luciferase assay and the growth in IFNγ-activated BMDMs is expressed relative to growth in naïve BMDMs. Data are
displayed as connecting lines with mean of four independent experiments ± SEM. The significant difference was analyzed with two-way ANOVA with
Tukey’s multiple comparisons test. d CD-1 mice were i.p. infected with 100 tachyzoites of WT, Δmyr1, Δgra45, or Δgra45+ GRA45HA parasites and
survival of mice was monitored for 30 days. Data are displayed as Kaplan–Meier survival curves (n= 9 mice infected with WT or Δgra45 parasites, n= 5
mice infected with Δmyr1 parasites, and n= 4 mice infected with Δgra45+GRA45HA parasites). The significant difference was analyzed with Log-rank
(Mantel–Cox) test.
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Methods
Animals. Six to eight-weeks-old male/female C57BL/6 J mice (Stock No: 000664)
and A/J mice (Stock No: 000646) were purchased from The Jackson Laboratory. Six
to eight-weeks-old CD-1 female mice were purchased from Charles River
Laboratories (Strain Code: 022) and used for in vivo infection experiments. Six-
weeks-old female Brown Norway rats (Strain Code: 091) were purchased from
Charles River Laboratories. Mice and rats were housed in ventilated cages on corn
bedding and provided with water and chow ad libitum. Cages were all on one rack
at a housing density of five mice per cage and three rats per cage. The mice and rats
were allowed to acclimatize in our vivarium for at least a week undisturbed. The
animal room was on a 12-h light/12-h dark cycle, the temperature was maintained
at 22–25 °C, and the humidity range was 30–70%. Mice were monitored twice daily
by veterinarians, weighed daily, and cage bedding changed every two weeks. Mice
and rats were housed under pathogen-specific free conditions at the University of
California, Davis animal facility. All animal experiments were performed in strict
accordance with the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health and the Animal Welfare
Act, approved by the Institutional Animal Care and Use Committee at the Uni-
versity of California, Davis (UC Davis) (assurance number A-3433-01).
Culture of cells and parasites. Human foreskin fibroblasts (HFFs, gift from Dr.
John C. Boothroyd) were cultured in Dulbecco’s modified Eagle’s medium
(DMEM), 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/mL penicillin/
streptomycin, 10 mg/mL gentamicin. Mouse embryonic fibroblasts (MEFs, gift
from Dr. Anthony Sinai) were cultured in DMEM, 10% fetal bovine serum (FBS), 2
mM L-glutamine, 10 mM HEPES, 1x non-essential amino acids, 1 mM sodium
pyruvate, 100 U/mL penicillin/streptomycin, 10 µg/mL gentamicin. THP-1 cells
(ATCC TIB-202TM, gift from Dr. Daniel A. Bachovchin) were cultured in RPMI-
1640, 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/mL penicillin/
streptomycin, 10 µg/mL gentamicin. For differentiation, THP-1 cells were stimu-
lated with 100 nM phorbol 12-myristate 13-acetate (PMA, Sigma–Aldrich,
Cat#P1585) for 3 days and then rested for 1 day by replacing the differentiation
medium with complete medium without PMA before performing experiments.
Murine BMDMs were obtained by culturing murine bone marrow cells isolated
from the tibia and femur of C57BL/6 J mice or A/J mice in DMEM, 10% fetal
bovine serum (FBS), 2 mM L-glutamine, 10 mM HEPES, 1× non-essential amino
acids, 1 mM sodium pyruvate, 100 U/mL penicillin/streptomycin, 10 mg/mL gen-
tamicin and 20% L929 conditioned medium for 5–7 days. Rat BMDMs were
obtained by culturing rat bone marrow cells isolated from the tibia and femur of
Brown Norway rats in DMEM, 20% fetal bovine serum (FBS), 2 mM L-glutamine,
10 mM HEPES, 1× non-essential amino acids, 1 mM sodium pyruvate, 100 U/mL
penicillin/streptomycin, 10 mg/mL gentamicin and 30% L929 conditioned medium
for 5–7 days.
Toxoplasma gondii strains RH-Cas953, RH-Cas9Δhxgprt91, RHΔku80Δhxgprt92,
RHΔku80::MYR1-3xHA (kindly provided by Dr. John C. Boothroyd, see ref. 46),
RH-Luc+/Δhxgprt55, RH-Luc+/Δgra2255, RH-Luc+/ΔTGGT1_26995055 were
routinely passaged in vitro on monolayers of HFFs at 37 °C in 5% CO2.
Antibodies. Mouse monoclonal anti-GRA1 (clone TG-17.43) antibodies were
purchased from Biotem (Cat#BIO.018.4). Mouse monoclonal anti-GRA2 (clone
TG-17.179) and anti-GRA5 (clone TG-17.113) antibodies were purchased from
BioVision (Cat#A1298 and Cat#A1299). Mouse monoclonal anti-ROP2/3/4 (clone
T34A7) antibodies were described in ref. 93. Mouse monoclonal anti-SAG1 (clone
DG52) antibodies were described in ref. 94. Rabbit polyclonal anti-GRA795, anti-
MAF196, and anti-SAG1 antibodies were kindly provided by Dr. John C. Boot-
hroyd. Rat anti-HA (3F10) antibodies were obtained from Sigma–Aldrich
(Cat#11867431001). Mouse monoclonal anti-Ty (clone BB2) antibodies were
described in ref. 53. Mouse anti-Myc tag (9B11) antibodies were purchased from
Cell Signaling Technology (Cat#2276 S). Goat polyclonal anti-IRGA6 antibodies
(Cat#sc-11090) and anti-IRGB6 antibodies (Cat#sc-11079) were purchased from
Santa Cruz Biotechnology, Inc. Secondary antibodies horseradish peroxidase
(HRP)-conjugated Goat anti-Mouse/Rabbit/Rat IgG were purchased from Jackson
ImmunoResearch Laboratories Inc. (Cat#111-035-003/#112-035-003/#115-035-
003). Goat anti-Mouse IgG (Alexa Fluor 448/594, Cat#A11029/A11032), Goat anti-
Rat IgG (Alexa Fluor 594, Cat#A11007), Goat anti-Rabbit (Alexa Fluor 488/594,
Cat#A11008/A11037), Donkey anti-Rabbit IgG (Alexa Fluor 488, Cat#A21206),
and Donkey anti-Goat IgG (Alexa Fluor 594, Cat#A11058) secondary antibodies
were purchased from Thermo Fisher.
Plasmid construction. The pU6-Universal plasmid97 was used for generating the
plasmid containing sgRNAs targeting the candidate genes. Briefly, the constructs
were generated by annealing oligos containing the sequence of sgRNAs (Supple-
mentary Data 4) which were cloned into the BsaI (New England Biolabs)-digested
pU6-Universal plasmid. The pUPRT::DHFR-D (Addgene, Cat#58528) plasmid
backbone with PCR-amplification to remove the DHFR cassette was used to
generate the construct for making the GRA45 complementation. The promoter
region (~1500 bp upstream to the start codon) and the coding sequence of GRA45
were amplified and flanked with the HA epitope sequence before the stop codon.
The 3′-UTR region (~500 bp) was also amplified and assembled with the other two
fragments using Gibson Assembly (New England Biolabs, Cat#E2611L). For
making mutant versions of GRA45 (Fig. 5a), the complementation plasmids
containing the wild-type version of GRA45 from above were amplified using the
primers listed in Supplementary Data 4 followed by circularizing the PCR products
via Q5 Site-Directed Mutagenesis Kit (New England Biolabs, Cat#E0554S). All the
GRA45 mutant constructs were confirmed by sequencing. To construct the plas-
mid for generating the GRA45 endogenously HA-tagged strain, ~1300 bp upstream
of the stop codon of GRA45 was amplified by PCR and inserted into pLIC-3xHA-
DHFR by ligation-independent cloning92. All PCR primers are listed in Supple-
mentary Data 4.
Generation of parasite strains. Individual knockout of candidate genes was
performed using CRISPR-Cas997,98. To generate the knockout strains for candidate
fitness-conferring genes in IFNγ-activated BMDMs, plasmids containing sgRNAs
were co-transfected with NotI (New England Biolabs)-linearized pTKO99, which
contains the HXGPRT selection cassette and GFP99, into RH-Luc+/Δhxgprt
parasites at a ratio 5:1 of sgRNA to linearized pTKO plasmid. 24 h post-trans-
fection, populations were selected with 50 μg/mL mycophenolic acid
(Sigma–Aldrich, Cat#89287) and 50 μg/mL xanthine (Sigma–Aldrich, Cat#X3627)
and cloned by limiting dilution (Supplementary Fig. 4a). Individual knockout
clones were confirmed by PCR (Supplementary Fig. 4d–f). In addition to gen-
erating knockouts in the RH-Luc+/Δhxgprt strain, the RH-Cas9/Δhxgprt strain91
was used to generate Δgra22, Δrom1, and Δgra7 parasites (Supplementary Fig. 4g,
i) using the same strategy. To generate the GRA45 complemented strain (Sup-
plementary Fig. 4b), the RH-Luc+/Δgra45 parasites were co-transfected with
plasmids containing sgRNAs specifically targeting the UPRT locus and SalI (New
England Biolabs)-linearized pUPRT::GRA45HA plasmid at a ratio 1:5 of sgRNAs
to linearized plasmid. After the first two complete lysis cycles, populations were
selected with 10 μM 5-fluoro-2-deoxyuridine (FUDR) (Sigma–Aldrich, Cat#F0503)
for another two complete lysis cycles. Individual clones were isolated by limiting
dilution and the presence of GRA45HA was determined by immunofluorescence
assay (IFA) and by PCR to confirm the integration into the UPRT locus (Sup-
plementary Fig. 4d). The strains expressing various GRA45 mutations were gen-
erated using the same strategy as for the complemented strain construction and
confirmed by PCR (Supplementary Fig. 4k). The GRA45 knockout in the
RHΔku80::MYR1-3xHA strain was generated by co-transfecting plasmids con-
taining sgRNAs targeting the GRA45 locus along with an amplicon harboring
GRA45 homology regions (60 bp) surrounding a pyrimethamine-resistant
(DHFR*) cassette (Supplementary Fig. 4c). Individual knockout clones were grown
in medium supplemented with 3 μM pyrimethamine (Sigma–Aldrich, Cat#46706)
followed by limiting dilution and subsequent screening by PCR for correct inte-
gration of DHFR* into the GRA45 locus (Supplementary Fig. 4j). GRA45 endo-
genously HA-tagged parasites were made in the RHΔku80Δhxgprt strain by
transfection with the plasmid pLIC-GRA45-3xHA-DHFR. Transfected parasite
populations were selected with 3 μM pyrimethamine and cloned by limiting dilu-
tion. The presence of GRA45-3xHA was determined by immunofluorescence
assays.
Toxoplasma gondii CRISPR-Cas9 mediated genome-wide loss-of-function
screens. At least 5 × 108 parasites were transfected with a mixture of pU6-DHFR
plasmids53 (100 μg for each 1 × 108 of parasites) containing 10 different sgRNAs
against each of the 8156 Toxoplasma genes. A monolayer of HFFs was subsequently
infected with the parasites (MOI= 0.5) and grown for 24 h in DMEM containing
1% FBS, 2 mM L-glutamine, 100 U/mL penicillin/streptomycin, and 40 µM
chloramphenicol (CAT) (Sigma–Aldrich, Cat#C0378-5). Subsequently, the med-
ium was removed and replaced with DMEM containing 10% FBS, 2 mM L-glu-
tamine, 10 mM HEPES, 1× non-essential amino acids, 1 mM sodium pyruvate, 100
U/mL penicillin/streptomycin, 10 µg/mL gentamicin, 40 µM CAT, 1 µM pyr-
imethamine, and 10 µg/mL DNase I (New England Biolabs, Cat#M0303S) for three
or four passages. To maintain the coverage of the library, at least 10% of the
parasites harvested from each lysis were passed to the next round. To perform the
screen in murine macrophages, BMDMs isolated from C57BL/6 J mice were sti-
mulated with: 100 ng/mL murine IFNγ (PeproTech, Cat#315-05) for 24 h for
screen 1 (S1), 1 ng/mL IFNγ for 24 h for screen 2 (S2), or 100 ng/mL IFNγ for 4 h
for screen 3 (S3). Both naïve BMDMs and IFNγ-activated BMDMs were infected
with the mutant pool derived from the 3rd or 4th passage in HFFs at an MOI of 0.5
(1 × 107 parasites). After 48 h infection (the time the mutant parasites nearly
egressed from the host cells), the parasites were harvested, counted and at least 20%
of the population were used to infect macrophages that had undergone the same
stimulation until the 3rd passage (Fig. 1b). For each passage a pellet of 1 × 107
parasites were collected and used for genomic DNA extraction and PCR amplifi-
cation of the sgRNA with a barcoding primer. The sample was sent for Illumina
sequencing at the University of California Davis Genomic Center on a NextSeq
(Illumina) with single-end reads using primers (P150 and P151) listed in Supple-
mentary Data 4.
sgRNA selection and screen analysis were performed using custom software as
previously described53,100 that will be provided upon request. Statistical analyses
were performed in R (www.R-project.org) version 3.6.3 and Excel (Microsoft
Office) version 16.0. Illumina sequencing reads were matched against the sequences
of the sgRNA library. The number of exact matches was counted and considered as
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raw read numbers. The abundance of each sgRNA was normalized to the total
number of reads. To do the log2 transfer, sgRNAs that had zero reads were assigned
a pseudo-count corresponding to 0.9, which is 90% of the lowest sgRNA read in the
sample. Only sgRNA whose abundance was above the 5th percentile in the input
(library) were further considered for the analysis. The “fitness” score was calculated
as the average log2-fold change of the top five scoring sgRNAs for each given gene,
and the mean fitness in the three screens is reported. The Pearson correlation
between each sample from different screens was calculated101. One-sided Wilcoxon
signed-rank test was used to calculate the probability of each gene being fitness
conferring by comparing their fitness to the 497 control genes. Cohen’s d
calculation was used to measure the effect size of fitness scores for each gene. The
fitness-conferring genes were defined if they met a significance threshold of p ≤
0.05 from one-sided Wilcoxon signed-rank test and Cohen’s d ≥ 0.8 with
expression in the murine macrophages (FPKM > 1)56. The criteria used to identify
the high-confidence genes were described in Table 1.
RNA-seq. 3 × 106 murine BMDMs were seeded overnight in 6-well plates prior to
stimulations. For the stimulated samples, IFNγ (100 ng/mL) was added to each well
for 4 or 24 h before harvesting the cells for total RNA extractions. The mRNA was
purified by polyA-tail enrichment (Dynabeads mRNA Purification Kit, Thermo
Fisher, Cat#61006), fragmented into 200–400 basepairs, and reverse transcribed
into cDNA before adding Illumina sequencing adapters to each end102. Libraries
were barcoded, multiplexed into four samples per sequencing lane in the Illumina
HiSeq 2000, and sequenced from both ends resulting in 50 bp reads after discarding
the barcodes. The RNA-sequencing reads were mapped to the mouse genome
(mm10) using Bowtie (version 2.0.2)103 and Tophat (version 2.0.4)104 and tran-
script abundance estimated in cufflinks (version 2.2.1)105.
Bioinformatic analysis. GSEA57 was used to determine if Toxoplasma genes that
determine fitness in specific conditions were enriched in the functional annotation.
GO enrichment analysis was performed using online tools available at ToxoDB.org.
In addition, the genes conferring fitness in specific conditions were analyzed using
an in-house database that contained information on GO, protein family domains
(Interpro), KEGG enzyme EC numbers, localization to specific organelles, amongst
others. Pathways that were enriched are indicated in Supplementary Data 2. For
enrichment analysis of BMDM pathways stimulated with IFNγ vs. unstimulated,
the GSEA program (version 4.0.3) and Molecular Signatures Database (MSigDB,
version 7.1) was used57,106,107. Psi-blast was used to find orthologues of proteins
under investigation in other species. Alignments of GRA45 with its orthologs were
made using PRALINE108, and the results (Supplementary Fig. 7a) were used as
input for HHpred109 to predict similarity to secondary structures of other proteins.
In addition, the SWISS-MODEL server110 and I-TASSER analysis70 were used for
the homology modeling of protein structures.
Plaque assay. Freshly confluent 24-well plates of HFFs or MEFs were infected
with 100 parasites for each well and the plates were incubated at 37 °C without
disturbing for 5 days. The total number of plaques in HFFs was observed using a
Nikon TE2000 inverted microscope. To measure the parasite growth in MEFs, the
area of each individual plaque was captured and analyzed using the above
microscope equipped with Hamamatsu ORCA-ER digital camera, and NIS Ele-
ments Imaging Software, respectively. For each independent experiment, at least 40
plaques from technical duplicate wells were imaged.
Luciferase assay. Luciferase assays were performed to determine the fitness of
knockout strains in IFNγ-activated macrophages. For murine and rat macrophages,
BMDMs in 96-well plates (1 × 105 cells/well) were stimulated with 1 ng/mL or 5 ng/
mL murine or rat IFNγ (R&D System, Cat#585-IF-100) for 24 h followed by
infection with wild-type luciferase-expressing parasites or knockout parasites at
two different MOIs (MOI= 0.5 and 1). For human macrophages, PMA-
differentiated THP-1 cells in 96-well plates (1 × 105 cells/well) were stimulated with
2.5 ng/mL or 5 ng/mL human IFNγ (BIO-RAD, Cat#PHP050) for 24 h followed by
parasite infection. A plaque assay was set up in HFFs at the same time to determine
the parasite viability of each parasite strain. After 24 h infection, the cells in 96-well
plates were lysed using the lysis buffer of Luciferase Assay System (Promega,
Cat#E1500) followed by adding luciferin for the measurement of luciferase activity
using a single-channel luminometer (Turner BioSystems). Raw luciferase reads
(RLU) of unstimulated infected cells was considered as 100 percent and relative
parasite growth in IFNγ-activated macrophages was calculated. To make com-
parisons between wild-type and knockout parasites, “real” MOI was matched from
the plaque assay results.
Growth competition. The BMDMs were left unstimulated or stimulated with IFNγ
(1 ng/mL) for 24 h followed by infection with a 1:1 mixed ratio of GFP-expressing
wild-type parasites and GFP-negative knockout parasites (Δgra22 or Δrom1). The
mixed parasites were allowed to grow in the BMDMs for three lytic cycles. Plaque
assays of the mixed parasites were performed in HFFs before putting into the
BMDMs and after the 3rd passage in the BMDMs, and the number of GFP-positive
vs. GFP-negative plaques were counted to determine the ratio of wild-type and
knockout parasites in naïve and IFNγ-activated BMDMs.
Immunofluorescent assay. To determine the localization of GRA45 in extra-
cellular parasites, RHΔku80Δhxgprt::GRA45-3xHA tachyzoites released from
syringe-lysed HFFs were loaded onto coverslips and fixed with 4% Paraf-
ormaldehyde (PFA) for 20 min followed by permeabilization/blocking with PBS
containing 3% (w/v) BSA, 5% (v/v) goat serum and 0.1% Triton X-100. Co-
localization of GRA45 was detected by anti-HA antibodies along with antibodies
against ROP2/3/4, GRA1, GRA2, GRA5, GRA7, or SAG1. To determine the
localization of intracellular GRA45, HFFs grown on glass coverslips were infected
with RHΔku80Δhxgprt::GRA45-3xHA parasites for 24 h, fixed with 4% PFA for 20
min, permeabilized/blocked with PBS containing 3% (w/v) BSA, 5% (v/v) goat
serum and 0.1% Triton X-100 (or 0.2% Saponin), followed by incubated with
antibodies against the HA epitope tag together with antibodies against ROP2/3/4,
GRA1, GRA2, GRA5, GRA7, or SAG1 at 4 °C overnight. To check the PVM
localization of GRA5 or GRA7, HFFs grown on glass coverslips were infected with
wild-type, Δgra45 or Δgra45+GRA45HA strains in the RH-Luc+/Δhxgprt back-
ground for 24 h followed by fixation with 4% PFA, permeabilization with 0.2%
Saponin and blocking with PBS containing 3% (w/v) BSA, 5% (v/v) goat serum and
0.1% Saponin. The coverslips were incubated with antibodies against GRA5 or
GRA7 for 1 h at room temperature. MAF1 localization was observed in the HFFs
infected wild-type, Δgra45 parasites or Δgra45 parasites complemented with wild-
type or mutant versions of GRA45. At 4 or 24 h post-infection, the cells were fixed
with 4% PFA, permeabilized/blocked with PBS containing 3% (w/v) BSA, 5% (v/v)
goat serum and 0.1% Triton X-100 followed by incubation with MAF1 anti-
bodies96. To check the PVM localization of GRA23 or export of GRA16 and
GRA24, HFFs grown on glass coverslips were infected with wild-type, Δmyr1,
Δgra45 parasites or Δgra45 parasites complemented with wild-type or mutant
versions of GRA45 transiently expressing GRA23-HA-FLAG, GRA16-HA-FLAG,
or GRA16-Ty50, GRA24-HA-FLAG or GRA24-Ty50 for 20–24 h followed by
fixation, permeabilization and blocking as described above. The coverslips were
incubated with anti-SAG1 antibodies and anti-HA antibodies or anti-Ty antibodies
at 4°C overnight. To observe the localization of GRA44, HFFs infected with wild-
type, Δgra45 or Δgra45+GRA45HA strains transiently expressing GRA44-Myc80
for 20 h were fixed, permeabilized and blocked as described above followed by
incubation with anti-Myc antibodies at 4°C overnight. After incubating with Alexa
Fluor 488/594 secondary antibodies and DAPI, the coverslips were mounted with
Vecta-Shield mounting oil and the microscopy was performed with NIS-Elements
software (Nikon) and a digital camera (CoolSNAP EZ; Roper Scientific) connected
to an inverted fluorescence microscope (Eclipse Ti-S; Nikon) and either phase
contrast or DIC imaging. To compare the localization of GRAs in various strains,
the images were taken at identical exposure times for each channel. To quantify the
localization of GRA5, GRA7, and MAF1 at 24 h p.i., at least 100 vacuoles con-
taining four or more parasites were observed. To quantify the localization of
GRA23 and GRA44, at least 50 vacuoles containing two or more parasites were
observed. To quantify the intensity of GRA16 and GRA24 in host nucleus, at least
30 host cells containing a single PV with 4 or more parasites were observed.
IRGA6/IRGB6 coating assay. 1 × 105 of C57BL/6 J murine BMDMs were plated
on coverslips in 24-well plates and rested for 24 h followed by stimulated with
5 ng/mL of murine IFNγ for another 24 h. The stimulated BMDMs were infected
with freshly lysed wild-type, Δgra45, Δgra22, ΔTGGT1_263560, or
ΔTGGT1_269950 parasites for 1 h followed by washing with PBS for 3–5 times to
remove uninvaded parasites, fixation with 4% PFA, permeabilization with 0.2%
Saponin and blocking with PBS containing 3% (w/v) BSA, 5% (v/v) goat serum and
0.1% Saponin. The coverslips were incubated with anti-SAG1 antibodies along with
antibodies against IRGA6 or IRGB6 for 1 h at room temperature followed by
incubation with Alexa Fluor 488/594 secondary antibodies and DAPI for 30 min at
room temperature. The coverslips were mounted with Vecta-Shield mounting oil
and the microscopy was performed as described above. For each independent
experiment, at least 200 vacuoles of each strain were observed and the percentage
of IRGA6- or IRGB6-positive vacuoles was quantified.
Cell fractionation. Purified extracellular parasites were washed with PBS and
resuspended in cold PBS containing 1× protease and phosphatase inhibitors
(Thermo Fisher, Cat#78444). Parasites were lysed by six freeze/thaw (F/T) cycles
using a dry ice ethanol bath (−70 °C) and a 37 °C bath. 1/3 of the F/T lysate was
kept in PBS, 1/3 in 1% NP-40, and 1/3 in 1% Triton X-100 for 30 min at 4 °C under
rotation. The PBS, NP-40, and Triton X-100 treated lysates were separated by high-
speed spin 30 min at 20,000 × g. The PBS supernatant was precipitated with TCA
(Trichloroacetic Acid) and the supernatant fraction of NP-40 or Triton X-100
extraction were cold acetone precipitated.
Immunoblotting. Samples from different fractions of the extracellular were boiled
for 5 min in sample buffer, separated by SDS-PAGE, and transferred to poly-
vinylidene difluoride (PVDF) membranes. Membranes were blocked in 5% milk in
TBS supplemented with 1% Tween-20 (TBS-T) for 30 min at room temperature
and then incubated overnight at 4 °C with primary antibody in the blocking buffer.
The GRA2 blot was subsequently incubated with HRP-conjugated anti-mouse
secondary antibodies. The GRA7 and SAG1 blots were incubated with HRP-
conjugated anti-rabbit secondary antibodies. The HA blot was incubated with
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HRP-conjugated anti-rat secondary antibodies. The HRP was detected using an
enhanced chemiluminescence (ECL) kit (BIO-RAD, Cat#1705060). Blot pictures
were acquired using a FluorChem E system (ProteinSimple). Between each blot, the
membranes were stripped by incubation in stripping buffer (Thermo Fisher,
Cat#46428) for 20 min and subsequently washed three times with TBS-T. The
absence of residual HRP signal on the membrane was tested by using the ECL kit
(BIO-RAD, Cat#1705060) and image acquisition. Then, the membrane was
blocked prior to incubation with the next primary antibody. The quantification of
the bands intensity was done using the Volume Tools of Image Lab 6.1 software
(BIO-RAD).
In vivo infection. The mice were randomly assigned to experimental groups (the
exact number of mice per group is indicated in the figure legends) at the start of the
experiment. Toxoplasma tachyzoites were harvested from cell culture and released
by passage through a 27-gauge needle, followed by a 30-gauge needle. CD-1 mice
were intraperitoneally (i.p.) infected with 100 tachyzoites of each strain and
parasite viability of the inocula was determined in a plaque assay after infection.
The mice were monitored for 30 days p.i., and the number of dead mice per group
was observed every individual day.
Statistical Tests. All statistical analyses were performed using Prism (GraphPad)
version 8.0. All the data are presented as mean ± standard error of mean (SEM),
and the exact n values are mentioned in the figure legends. For all the calculations
p < 0.05 are considered as significant. To compare parasite growth of the knockouts
vs. wild-type parasites in IFNγ-activated cells, paired t-test was used. For the data
with more than two groups with one variable, One-way ANOVA with Tukey’s
multiple comparisons test was used. For one variable test with two groups, the two-
way ANOVA with Tukey’s multiple comparisons test was used. Survival experi-
ments were analyzed using the Log-rank (Mantel–Cox) test.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The authors declare that all data supporting the findings of this study are available within
the article and its Supplementary Information files or are available from the authors upon
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with the accession code PRJNA664106 and are provided in Supplementary Data 3. The
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